Skip to main content
. 2018 Sep 10;2018(9):CD007287. doi: 10.1002/14651858.CD007287.pub4

NCT02498665.

Trial name or title A phase I clinical study of DSP‐7888 dosing emulsion in adult patients with advanced malignancies
Methods Non‐randomised phase I
Participants 96 participants with advanced malignancies
Interventions WT1 protein‐derived peptide vaccine (DSP‐7888)
Outcomes DLT
Survival
Immune response
Starting date November 2015
Contact information  
Notes Recruiting, April 2018